研究
2021 研究業績・論文発表
論文
Okuhata K, Tamura M, Monzen H, Nishimura Y.
Dosimetric characteristics of a thin bolus made of variable shape tungsten rubber for photon radiotherapy.
Phys Eng Sci Med. 2021;44(4):1249-1255.
Wakabayashi K, Monzen H, Tamura M, Takei Y, Okuhata K, Anami S, Doi H, Nishimura Y.
A novel real-time shapeable soft rubber bolus for clinical use in electron radiotherapy.
Phys Med Biol. 2021;66(18).
Nakamura K, Okuhata K, Tamura M, Otsuka M, Kubo K, Ueda Y, Nakamura Y, Nakamatsu K, Tanooka M, Monzen H, Nishimura Y.
An updating approach for knowledge-based planning models to improve plan quality and variability in volumetric-modulated arc therapy for prostate cancer.
J Appl Clin Med Phys. 2021;22(9):113-122.
Tamura M, Monzen H, Matsumoto K, Otsuka M, Nishimura Y.
Feasibility study of a photochromic diarylethene film as a clinical dosimeter for kV X-rays.
Radiat Meas. 2021;145:106608.
Wada Y, Monzen H, Tamura M, Otsuka M, Inada M, Ishikawa K, Doi H, Nakamatsu K, Nishimura Y.
Dosimetric Evaluation of Simplified Knowledge-Based Plan with an Extensive Stepping Validation Approach in Volumetric-Modulated Arc Therapy-Stereotactic Body Radiotherapy for Lung Cancer.
J Med Phys. 2021;46(1):7-15.
Okuhata K, Monzen H, Tamura M, Matsumoto K, Otsuka M, Kubo K, Ueda Y, Uehara T, Doi H, Ishikawa K, Nishimura Y.
lan Complexity and Delivery Accuracy of Knowledge-based Volumetric Modulated Arc Therapy Plans with Single Optimization for Oropharyngeal Cancer.
PAnticancer Res. 2021;41(6):2925-2931.
Wakabayashi K, Monzen H, Tamura M, Matsumoto K, Takei Y, Nishimura Y.
Dosimetric evaluation of skin collimation with tungsten rubber for electron radiotherapy: A Monte Carlo study.
J Appl Clin Med Phys. 2021;22(4):63-70.
Inoue E, Okajima K, Doi H, Fukuda K, Oguma Y, Ri A, Nishikawa D, Yane K, Matsuura T, Nishimura Y.
Factors Predictive of the Development of Hypothyroidism after Intensity-Modulated Radiation Therapy for Pharyngeal Cancer.
Acta Oto-Laryngologica. 2021;141(11):1022-1026.
Hamada A, Soh J, Hata A, Nakamatsu K, Shimokawa M, Yatabe Y, Oizumi H, Tsuboi M, Horinouchi H, Yoshino I, Tanahashi M, Toyooka S, Okada M, Yokomise H, Yamashita M, Nishimura Y, Yamamoto N, Nakagawa K, Mitsudomi T.
Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial (WJOG 12119L).
Clin Lung Cancer. 2021;22(6):596-600.
Miyawaki T, Kenmotsu H, Harada H, Ohde Y, Chiba Y, Haratani K, Okimoto T, Sakamoto T, Wakuda K, Ito K, Uemura T, Sakata S, Kogure Y, Nishimura Y, Nakagawa K, Yamamoto N.
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L).
BMC Cancer. 2021;21(1):1121.
Arakawa Y, Sasaki K, Mineharu Y, Uto M, Mizowaki T, Mizusawa J, Sekino Y, Ono T, Aoyama H, Satomi K, Ichimura K, Kinoshita M, Ohno M, Ito Y, Nishikawa R, Fukuda H, Nishimura Y, Narita Y;
Brain Tumor Study Group and Radiation Therapy Study Group of the Japan Clinical Oncology Group. A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII).
BMC Cancer. 2021;21(1):1105.
Akamatsu H, Murakami H, Harada H, Shimizu J, Hayashi H, Daga H, Hasegawa Y, Kim YH, Kato T, Tokunaga S, Nishimura Y, Yamamoto N, Nakagawa K.
Gefitinib With Concurrent Thoracic Radiotherapy in Unresectable Locally Advanced NSCLC With EGFR Mutation; West Japan Oncology Group 6911L.
J Thorac Oncol. 2021;16(10):1745-1752.
Sakisuka T, Kashiwagi N, Doi H, Takahashi H, Arisawa A, Matsuo C, Masuda Y, Inohara H, Sato K, Outani H, Outani H, Ishii K, Tomiyama N.
Prognostic factors for bone metastases from head and neck squamous cell carcinoma: A case series of 97 patients
Molecular and Clinical Oncology. 2021;15(5):246.
Murakami N, Mori T, Machida R, Kodaira T, Ito Y, Shikama N, Konishi K, Matsumoto Y, Murakami Y, Nakamura N, Yamashita H, Yorozu A, Yoshimura M, Inoue K, Nozaki M, Ishikura S, Itami J, Nishimura Y, Kagami Y.
Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer.
Laryngoscope. 2021;131(7):1522-1527.
Nozaki M, Kagami Y, Machida R, Nakamura K, Ito Y, Nishimura Y, Teshima T, Saito Y, Nagata Y, Matsumoto Y, Akimoto T, Hiraoka M; Japan Clinical Oncology Group,
Radiation Therapy Study Group. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.
Jpn J Clin Oncol. 2021;51(6):865-872.
Yamamoto N, Harada H, Okamoto I, Masuda N, Hayakawa K, Satouchi M, Soejima T, Nishio M, Kozuka T, Takeda K, Tanaka M, Seto T, Sasaki T, Tsubouchi H, Kakurai Y, Nishimura Y, Nakagawa
K.Clin Lung Cancer. Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2021;22(2):134-141.
Kobayashi N, Takano S, Ito K, Sugiura M, Ogawa M, Takeda Y, Okubo N, Suzuki A, Tokuhisa M, Kaneta T, Utsunomiya D, Hata M, Inoue T, Hosono M, Kinuya S, Ichikawa Y.
Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors.
Ann Nucl Med. 2021 Dec;35(12):1332-1341.
Uemura H, Masumori N, Takahashi S, Hosono M, Kinuya S, Sunaya T, Horio T, Okayama Y, Kakehi Y.
Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents.
Int J Clin Oncol. 2021 Apr;26(4):753-763.
Kamima T, Ueda Y, Fukunaga JI, Tamura M, Shimizu Y, Muraki Y, Yoshioka Y, Kitamura N, Nitta Y, Otsuka M, Monzen H.
Knowledge-based planning using pseudo-structures for volumetric modulated arc therapy (VMAT) of postoperative uterine cervical cancer: a multi-institutional study.
Rep Pract Oncol Radiother. 2021;26(6):849-860.
Kawai Y, Tamura M, Amano M, Kosugi T, Monzen H.
First Clinical Experience of Tungsten Rubber Electron Adaptive Therapy With Real-time Variable-shape Tungsten Rubber.
Anticancer Res. 2021;41(2):919-925.